NEW YORK, Nov 27 – Aclara BioSciences said that a trial judge has granted the company’s request to reduce a $52 million jury award in a microfluidics trade secret lawsuit with Caliper Technologies by $17 million .

“In addition, we intend to appeal the remaining $35 million and believe that we have strong grounds on which to base that appeal," Joseph Limber, president and CEO of Aclara said in a statement released Sunday.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.